Trachea neoplasm

Summary

Trachea neoplasm (MONDO:0021210) is a cancer and 1 clinical trial. A subtype of tracheal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	trachea neoplasm
Mondo ID	MONDO:0021210
EFO	EFO:1001437
MeSH	D014134
NCIT	C3419
UMLS	C0040582
MedGen	21602
Anatomy (UBERON)	UBERON:0003126
Is cancer (heuristic)	yes

Also known as: neoplasm of the trachea · neoplasm of trachea · trachea neoplasm (disease) · trachea tumor · trachea tumour · tracheal neoplasm · tracheal tumor · tracheal tumour · tumor of the trachea · tumor of trachea · tumour of the trachea · tumour of trachea

Data availability: 1 HPO phenotype.

Disease family

This is a subtype of tracheal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › lower respiratory tract disorder › tracheal disorder › trachea neoplasm

Related subtypes (7): tracheal calcification, tracheal stenosis, chronic obstructive pulmonary disease, tracheitis, laryngotracheoesophageal cleft, isolated tracheo-esophageal fistula, congenital tracheomalacia

Subtypes (2): tracheal cancer, benign neoplasm of trachea

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE1/PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01331863	PHASE1/PHASE2	COMPLETED	Airway and/or Pulmonary Vessels Transplantation